Skip to main content
. 2018 Jun 26;17:1533033818782793. doi: 10.1177/1533033818782793

Table 4.

Allele Frequencies of the 5 SNPs of TNF-α Promoter Gene by Groups.a

SNPs Allele frequency χ2/P b OR (95% CI) P
Control group (N = 494) Cervical Cancer group (N = 452)
Homozygous Heterozygous Homozygous Heterozygous G/(C*) A/(T*) G/(C*) A/(T*)
rs361525 0.962 (475) 0.038 (19) 0.892 (403) 0.108 (49) χ2 = 17.3/P < .001 0.33 (0.19-0.57) 3.04 (1.76-5.25) <.01 <.01
rs1800629 0.858 (424) 0.142 (70) 0.701 (317) 0.299 (135) χ2 = 34.3/P < .001 0.39 (0.28-0.54) 2.58 (1.87-3.56) <.01 <.01
rs1800750 0.996 (492) 0.004 (2) 0.996 (450) 0.004 (2) χ2 = 0.008/P = 0.929 1.09 (0.15-7.79) 0.92 (0.13-6.52) .929 .929
rs1799964 0.836 (413) 0.164 (81) 0.617 (279) 0.383 (173) χ2 = 57.52/P < .001 0.32 (0.23-0.43) 3.16 (2.33-4.28) <.01 <.01
rs673 0.978 (483) 0.022 (11) 0.973 (440) 0.027 (12) χ2 = 0.182/P = 0.669 0.84 (0.37-1.91) 1.20 (0.52-2.74) 0.6697 0.6697

Abbreviations: OR, odds ratio; SNP, single nucleotide polymorphisms; TNF-α, tumor necrosis factor-α.

a OR using the recessive genetic model (OR = 1, indicating that the factor does not influence the occurrence of the disease; OR > 1, indicating that the factor is a risk factor; OR < 1, indicating that the factor is protective factors). The allele base of the rs361525 allele is C, T, CC, and TT being homozygous, CT being heterozygous; the other 4 sites are G, A, GG, and AA being homozygous, and AG being heterozygous.

b Used χ2 test.